• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

CW9:GR

6.935 EUR 0.295 4.44%

As of 03:00:57 ET on 04/23/2014.

Snapshot for Compugen Ltd (CW9)

Open: 7.029 Day's Range: 6.935 - 7.104 Volume: 0
Previous Close: 6.640 52wk Range: 3.774 - 10.305 1-Yr Rtn: +73.42%

Stock Chart for CW9

No chart data available.
  • CW9:GR 6.935
  • 1D
  • 1M
  • 1Y
6.640
Interactive CW9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CW9

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.2900
Est. PEG Ratio -
Market Cap (M EUR) 335.01
Shares Outstanding (M) 48.31
30 Day Average Volume 174
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/25/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CW9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CW9

Compugen Ltd. develops solutions in the field of computational genomics. The Company provides its gene discovery tools to pharmaceutical, biotechnology, and other life sciences through its Web site, labOnWeb.com. Compugen is also seeking to commercialize the genes and proteins it discovers.

Anat Cohen-DayagPresident/CEODikla Czaczkes AxselbardChief Financial Officer
John J HunterVP:Antibody Research & Dev
More Company Profile & Key Executives for CW9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil